Vasopressin regulation of renal sodium excretion

Slides:



Advertisements
Similar presentations
Volume of Urine GFR ~ L/d Urine, ~ 0.5 – 15 L/d.
Advertisements

Antidiuretic Hormone (ADH)/ Vasopressin Cell Communication By: Alejandra Ospina, Megan Campbell.
Copyright © 2009 Pearson Education, Inc., publishing as Pearson Benjamin Cummings Reabsorption and Secretion  ADH  Hormone that causes special water.
Date of download: 6/25/2016 From: Nephrogenic Diabetes Insipidus Ann Intern Med. 2006;144(3): doi: / Water.
Joseph G. Verbalis, MD, Steven R
Hepatocyte growth factor in renal failure: Promise and reality
risk factors for hyponatremia with treatment of nocturia
Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Effect of arginine vasopressin and ANP on intracellular pH and cytosolic free [Ca2+] regulation in MDCK cells  Maria Oliveira-Souza, Margarida Mello-Aires,
Volume 60, Issue 2, Pages (August 2001)
Joseph G. Verbalis, MD, Steven R
Volume 84, Issue 3, Pages (September 2013)
Volume 79, Issue 8, Pages (April 2011)
Early aldosterone up-regulated genes: New pathways for renal disease?
Volume 78, Issue 2, Pages (July 2010)
Hepatocyte growth factor in renal failure: Promise and reality
Elena Kamynina, Christophe Debonneville, Robert P. Hirt, Olivier Staub 
Volume 79, Issue 8, Pages (April 2011)
Joseph G. Verbalis, MD, Steven R
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Biff F. Palmer, Deborah J. Clegg  American Journal of Kidney Diseases 
Volume 67, Issue 2, Pages (February 2005)
Volume 79, Issue 1, Pages (January 2011)
Volume 78, Issue 10, Pages (November 2010)
Volume 94, Issue 5, Pages (November 2018)
Renal and extrarenal regulation of potassium
ANO1: an additional key player in cyst growth
Volume 66, Issue 6, Pages (December 2004)
Volume 71, Issue 5, Pages (March 2007)
Kamel S. Kamel, Martin Schreiber, Mitchell L. Halperin 
Urea for hyponatremia? Kidney International
Volume 85, Issue 5, Pages (May 2014)
Volume 66, Issue 2, Pages (August 2004)
Is it cerebral or renal salt wasting?
Volume 64, Issue 4, Pages (October 2003)
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load 
Vasopressin in chronic kidney disease: an elephant in the room?
Volume 80, Issue 1, Pages (July 2011)
Volume 69, Issue 6, Pages (March 2006)
Volume 83, Issue 6, Pages (June 2013)
Aquaporin gene delivery to kidney
Volume 76, Issue 8, Pages (October 2009)
Cyclooxygenase-2 in the kidney: good, BAD, or both?
Volume 67, Issue 1, Pages (January 2005)
Karl Kunzelmann, Rainer Schreiber, Anissa Boucherot 
Volume 74, Issue 9, Pages (November 2008)
Disorders of the epithelial sodium channel: Insights into the regulation of extracellular volume and blood pressure  Principal discussant: John B. Stokes 
Mechanism of action of drugs commonly used to treat hyponatremia.
Signaling path of the action of AVP on distal K+ secretion
An Unusual Case of Metabolic Alkalosis: A Window Into the Pathophysiology and Diagnosis of This Common Acid-Base Disturbance  F. John Gennari, MD, Sarah.
Volume 79, Issue 4, Pages (February 2011)
Acute renal failure: From renal physiology to the renal transcriptome
Dr Antonio Di Stefano, Sylvie Jounier, Monika Wittner 
Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Volume 77, Issue 4, Pages (February 2010)
S. Susan Hedayati, Essam F. Elsayed, Robert F. Reilly 
Mineralocorticoid selectivity: Molecular and cellular aspects
Circadian regulation of renal function
Silvia B. Campos, Lucia H.K. Rouch, Antonio C. Seguro 
Molecular origin of the kidney clock
Toshinori Aoyagi, Taka-aki Koshimizu, Akito Tanoue 
AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla 
WNK kinases regulate sodium chloride and potassium transport by the aldosterone- sensitive distal nephron  A.R. Subramanya, C.-L. Yang, J.A. McCormick,
Volume 57, Issue 4, Pages (April 2000)
Volume 76, Issue 9, Pages (November 2009)
Y. Ren, J.L. Garvin, R. Liu, O.A. Carretero  Kidney International 
Biology of endothelin receptors in the collecting duct
Molecular biology of distal nephron sodium transport mechanisms
Nat. Rev. Nephrol. doi: /nrneph
Model of regulatory pathways for the mineralocorticoid receptor (MR) in intercalated cells: hyperkalemia and volume depletion. Model of regulatory pathways.
Presentation transcript:

Vasopressin regulation of renal sodium excretion James D. Stockand  Kidney International  Volume 78, Issue 9, Pages 849-856 (November 2010) DOI: 10.1038/ki.2010.276 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Vasopressin signal transduction. AC, adenylyl cyclase; AQP2, aquaporin 2; AVP, arginine vasopressin; cAMP, cyclic adenosine monophosphate; ENaC, epithelial Na+ channel; MR, mineralocorticoid receptor; Nedd4-2, neural precursor cell expressed developmentally downregulated 4-2; Sgk, serum and glucocorticoid-inducible kinase. Kidney International 2010 78, 849-856DOI: (10.1038/ki.2010.276) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Vasopressin increases papillary sodium and urea concentrations while concentrating urine. Figure regenerated from data presented originally in Levitin et al.42 AVP, arginine vasopressin. Kidney International 2010 78, 849-856DOI: (10.1038/ki.2010.276) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Vasopressin via V2 receptors (V2Rs) decreases sodium excretion (excr.) while concentrating urine. Figure originally presented in Perucca et al.26 and partially reproduced here. Mean data presented as fold changes under experimental (Exp) conditions as normalized to starting (basal) values in the same rats. Paired t test vs basal; *P<0.05, **P<0.01, ***P<0.001. BW, body weight. Kidney International 2010 78, 849-856DOI: (10.1038/ki.2010.276) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 4 Schematic representation of the dose-dependent effects of AVP on sodium excretion rate and dissociation of these effects into V2 receptor (V2R)- and V1aR-mediated responses. Figure from Perucca et al.26 The abscissa represents increasing levels of plasma AVP from left (undetectable) to right. A corresponds to the lowest values of AVP, which reduce urine flow rate but not sodium excretion rate. V2R antinatriuretic and V1aR natriuretic effects are depicted as sigmoid curves with different thresholds (B for V2R and C for V1 effects). (B′ and C′) Correspond to the maximum effects depending on each receptor type, respectively. M corresponds to the value of plasma AVP for which the antinatriuretic and the natriuretic effects compensate each other. This value probably fluctuates according to a number of factors influencing the intensity of the responses mediated by each of the two receptor types. Insert showing dose-dependent effects of AVP on urine osmolality also from Perucca et al.26 Dashed line indicates AVP dosage that results in decreases in sodium excretion that favor reabsorption of free water (left) from those resulting in increases in sodium excretion compromising urine concentrating ability. AVP, arginine vasopressin; Exp, experimental. Kidney International 2010 78, 849-856DOI: (10.1038/ki.2010.276) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 5 Vasopressin increases amiloride-sensitive luminal to serosal sodium flux (Jlb; left) and transepithelial voltage (Ve; right) in the isolated perfused rat collecting tubule.Figures originally from Reif et al.,10 control (C), antidiuretic hormone (ADH) and ADH + amiloride (AMIL) indicated control plus vasopressin in the absence and presence of AMIL. Kidney International 2010 78, 849-856DOI: (10.1038/ki.2010.276) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 6 Vasopressin and water restriction increase epithelial Na+ channel (ENaC) activity (N and Po) in the isolated, split-open mouse collecting duct as assessed with patch clamp analysis. Figure originally from Bugaj et al.9 (a) Raw single channel current traces for cell-attached patches. (b and c) Summary data. *P<0.05 vs control. AVP, arginine vasopressin; PO, open probability. Kidney International 2010 78, 849-856DOI: (10.1038/ki.2010.276) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 7 Sodium and water retaining states act in synergy to increase epithelial NaC (ENaC) activity. Data originally from Bugaj et al.9 High and low [Na+] indicate isolated split-open collecting ducts from mice maintained with 2% [Na+] and nominally sodium-free feeding regimens, without (black) and with (gray) additional water deprivation. * vs +H2O, ** vs high [Na+]. Kidney International 2010 78, 849-856DOI: (10.1038/ki.2010.276) Copyright © 2010 International Society of Nephrology Terms and Conditions